{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:48:00Z","timestamp":1740170880932,"version":"3.37.3"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"9-10","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,25]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are a remarkable scientific achievement. The perspective on past viral vaccine performance and viral characteristics, such as incubation period, can help with messaging and instilling vaccine confidence. Protection against mild infection occurs in the short term (months), but the persistence of protection against severe disease will likely endure longer.<\/jats:p>","DOI":"10.1093\/milmed\/usac087","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T06:41:06Z","timestamp":1648622466000},"page":"233-234","source":"Crossref","is-referenced-by-count":0,"title":["Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: A Historical Viral Vaccine Perspective"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-1429","authenticated-orcid":false,"given":"David R","family":"Sayers","sequence":"first","affiliation":[{"name":"Department of the Air Force, AFMRA\/SG3PM , Falls Church, VA 22042, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"issue":"1","key":"2022082610302790400_R1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-0193-6","article-title":"Certainty of success: three critical parameters in coronavirus vaccine development","volume":"5","author":"Kaslow","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"18","key":"2022082610302790400_R2","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2021.18919","article-title":"The flawed science of antibody testing for SARS-CoV-2 immunity","volume":"326","author":"Abbasi","year":"2021","journal-title":"JAMA"},{"author":"Centers for Disease Control and Prevention: Vaccines by disease","key":"2022082610302790400_R3"},{"issue":"5152","key":"2022082610302790400_R4","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.15585\/mmwr.mm705152e3","article-title":"Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) variant cluster \u2014 Nebraska, November\u2013December 2021","volume":"70","author":"Jansen","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"author":"Centers for Disease Control and Prevention","key":"2022082610302790400_R5","article-title":"The possibility of COVID-19 after vaccination: breakthrough infections"},{"article-title":"Guidance for the DoD influenza vaccination program","year":"2020","author":"Defense Health Agency Procedural Instruction","key":"2022082610302790400_R6"},{"key":"2022082610302790400_R7","article-title":"Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients","author":"Madelon","year":"2021","journal-title":"medRxiv"},{"article-title":"Mandatory coronavirus disease 2019 vaccination of Department of Defense service members","year":"2021","author":"SecDef Memorandum","key":"2022082610302790400_R8"},{"author":"Centers for Disease Control and Prevention","key":"2022082610302790400_R9","article-title":"COVID data tracker"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/187\/9-10\/233\/45555379\/usac087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/187\/9-10\/233\/45555379\/usac087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:31:12Z","timestamp":1661509872000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/187\/9-10\/233\/6555820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":9,"journal-issue":{"issue":"9-10","published-online":{"date-parts":[[2022,3,30]]},"published-print":{"date-parts":[[2022,8,25]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usac087","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"type":"print","value":"0026-4075"},{"type":"electronic","value":"1930-613X"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,3,30]]}}}